Susceptibility to Leishmania major in IL-4 transgenic mice is not correlated with the lack of a Th1 immune response

Immunology and Cell Biology

Volumn 74, Issue 3, 1996, Pages 239-244

  Erb, Klaus J ^a,b   Blank, Christine ^a   Moll, Heidrun ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

Author keywords

IL 4 transgenic mice; leishmaniasis; Th1 cells; Th2 cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ANIMAL CELL; ARTICLE; CORRELATION FUNCTION; IMMUNE RESPONSE; INFECTION SENSITIVITY; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; SKIN LEISHMANIASIS;

EID: 0029973476     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1996.43     Document Type: Article

References (33)

1. Mosmann TR, Coffmann RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 1989; 7: 145-73.
2. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffmann RL. Two types of murine helper T cell clones: Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986; 136: 2348-57.
3. Kelso A, Gough NM. Co-expression of granulocyte-macrophage colony-stimulating factor, γ interferon, and interleukin 3 and 4 is random in murine alloreactive T-lymphocyte clones. Proc. Natl Acad. Sci. USA 1988; 85: 9189-93.
4. + T cell subset with an unrestricted cytokine profile. J. Immunol. 1989; 143: 518-25.
5. LeGros G, Ben-Sasson SZ, Seder RA, Finkelmann FD, Paul WE. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 1990; 172: 921-8.
6. + T cells from T cell receptor transgenic mice. J. Exp. Med. 1992; 176: 1091-8.
7. - cells that make TH2 cytokines and help B cells. Science 1993; 260: 1802-5.
8. + T cells secreting Th1 or Th2 cytokines. Immunity 1995; 2: 271-9.
9. Gross A, Ben-Sasson SZ, Paul WE. Anti-IL-4 diminishes in vivo priming for antigen-specific IL-4 production by T cells. J. Immunol. 1993; 150: 2112-20.
10. Kopf M, Le Gros G, Bachmann M, Lamers MC, Blüthmann H, Köhler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993; 362: 245-7.
11. + T cells in leishmaniasis. Immunol. Today 1989; 10: 40-5.
12. Heinzel FP, Sadick MD, Holaday BJ, Coffmann RL, Locksley RM. Reciprocal expression of interferon-gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 1989; 169: 59-72.
13. Bogdan C, Moll H, Solbach W, Röllinghoff M. Tumor necrosis factor-α in combination with interferon-γ, but not with interleukin-4 activates murine macrophages for elimination of Leishmania major amastigotes. Eur. J. Immunol. 1990; 20: 1131-5.
14. Liew FY, Li Y, Millot S. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 1990; 145: 4306-10.
15. Green SJ, Meltzer MS, Hibbs JB Jr, Nacy CA. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 1990; 144: 278-83.
16. Liew FY, Li Y, Severn A et al. A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur. J. Immunol. 1991; 21: 2489-94.
17. Oswald IP, Gazzinelli RT, Sher A, James SL. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J. Immunol. 1992; 148: 3578-82.
18. Doyle AG, Herbein G, Montaner LJ et al. Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma. Eur. J. Immunol. 1994; 24: 1441-5.
19. + effector cells default to the Th2 pathway in interferon-γ-deficient mice infected with Leishmania major. J. Exp. Med. 1994; 179: 1367-71.
20. Leal LM, Moss DW, Kuhn R, Mueller W, Liew FY. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. Eur. J. Immunol. 1993; 23: 566-9.
21. Erb KJ, Holtschke T, Muth K, Horak I, Schimpl A. T cell subset distribution and B cell hyperreactivity in mice expressing interleukin-4 under the control of major histocompatibility complex class I regulatory sequences. Eur. J. Immunol. 1994; 24: 1143-7.
22. + T cells in IL-4 transgenic mice. Eur. J. Immunol. 1995; 25: 1442-5.
23. Solbach W, Forberg K, Kammerer E, Bogdan C, Röllinghoff M. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically suceptible BALB/c mice. J. Immunol. 1986; 137: 702-7.
24. Taswell C. Limiting dilution assays for determination of immunocompetent cell frequencies. 1. Data analysis. J. Immunol. 1981; 126: 1614-19.
25. Spitalny GL, Havell EA. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J. Exp. Med. 1984; 159: 1560-5.
26. Prat M, Gribaudo G, Comoglio PM, Cavalio G, Landolfo S. Monoclonal antibodies against murine gamma interferon. Proc. Natl Acad. Sci. USA 1984; 81: 4515-19.
27. Trinchieri G. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann. Rev. Immunol. 1995; 13: 251-76.
28. + T-cell subset responses during murine leishmaniasis. Parasitol. Today 1994; 10: 190-2.
29. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, Locksley RM. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J. Exp. Med. 1990; 171: 115-27.
30. Belosevic M, Finbloom DS, Van der Meide PH, Slayter MV, Nacy CA. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 1989; 143: 266-74.
31. Sadick MD, Street N, Mosmann TR, Locksley RM. Cytokine regulation of murine leishmaniasis: interleukin 4 is not sufficient to mediate progressive disease in resistant C57BL/6 mice. Infect. Immun. 1991; 59: 4710-14.
32. Morris L, Troutt AB, McLeod KS, Kelso A, Handman E, Aebischer T. Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis. Infect. Immun. 1993; 61: 3459-65.
33. Melby PC, Andrade-Narvaez FJ, Darnell BJ, Valencia-Pacheco G, Tryon VV, Palomo-Cetina A. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infect. Immun. 1994; 62: 837-42.